BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11262176)

  • 1. Role of ERK activation in growth and erythroid differentiation of K562 cells.
    Woessmann W; Mivechi NF
    Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
    Woessmann W; Zwanzger D; Borkhardt A
    Cell Biol Int; 2004; 28(5):403-10. PubMed ID: 15193284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
    Kucukkaya B; Arslan DO; Kan B
    Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
    Moosavi MA; Yazdanparast R; Lotfi A
    Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase.
    Huang HM; Chang TW; Liu JC
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1247-52. PubMed ID: 15249224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Bcr-Abl function leads to erythroid differentiation of K562 cells via downregulation of ERK.
    Brózik A; Casey NP; Hegedus C; Bors A; Kozma A; Andrikovics H; Geiszt M; Német K; Magócsi M
    Ann N Y Acad Sci; 2006 Dec; 1090():344-54. PubMed ID: 17384279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
    Kohmura K; Miyakawa Y; Kawai Y; Ikeda Y; Kizaki M
    J Cell Physiol; 2004 Mar; 198(3):370-6. PubMed ID: 14755542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of TNF-alpha-induced apoptosis in polyamine-depleted IEC-6 cells is mediated through the activation of ERK1/2.
    Bhattacharya S; Ray RM; Johnson LR
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G479-90. PubMed ID: 14563673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM; Liu JC
    J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
    Seidman R; Gitelman I; Sagi O; Horwitz SB; Wolfson M
    Exp Cell Res; 2001 Aug; 268(1):84-92. PubMed ID: 11461121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S; Lunn JA; Santiskulvong C; Rozengurt E
    Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways.
    Sawafuji K; Miyakawa Y; Kizaki M; Ikeda Y
    Am J Hematol; 2003 Jan; 72(1):67-9. PubMed ID: 12508271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.
    Jacquel A; Colosetti P; Grosso S; Belhacene N; Puissant A; Marchetti S; Breittmayer JP; Auberger P
    Oncogene; 2007 Apr; 26(17):2445-58. PubMed ID: 17043649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
    Kawano T; Horiguchi-Yamada J; Saito S; Iwase S; Furukawa Y; Kano Y; Yamada H
    Leuk Res; 2004 Jun; 28(6):623-9. PubMed ID: 15120940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ERK mitogen-activated protein kinase in human cells by the mycotoxin patulin.
    Wu TS; Yu FY; Su CC; Kan JC; Chung CP; Liu BH
    Toxicol Appl Pharmacol; 2005 Sep; 207(2):103-11. PubMed ID: 16102563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.